Press Announcements > FDA approves first drug to treat tardive dyskinesia

Press Announcements > FDA approves first drug to treat tardive dyskinesia

FDA approves first drug to treat tardive dyskinesia

04/11/2017 05:35 PM EDT

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.